Lab Markers May Guide Lupus Biologic Use

• by Olivia Anderson

• March 19, 2026

Elevated interleukin-6 levels predict short-term flare in systemic lupus erythematosus

• by Borja del Carmelo Gracia Tello, José Miguel García-Bruñén, Luis Corredor, Natalia Allue Fantova, Eva Ma Calvo Beguería, Rubén García-Muñío, Laura Pérez Abad, Jimena Aramburu Llorente, Beatriz Martinez Muriel, Paula Vidales Miguélez, Roxanna Alexandra Morante Mendoza, Julia Martínez Artigot, Noelia Chicano Nieto, Jorge Álvarez Troncoso, Luis Martinez-Lostao, Adela Marín Ballvé

• May 8, 2026

Antibiotic Falls Short in Disc-Related Back Pain

A randomized trial found no greater pain reduction vs placebo, but questions remain about patients with type 1 Modic changes.

• by Kathryn Wighton

• May 28, 2026

• 5 min

Deep Remission Tied to RA Control

At 5 years, 63% of patients in the CliDR group maintained sustained remission compared with 38% in the non-CliDR group.

• by Andrea Surnit

• May 6, 2026

• 4 min